Moreover, a higher percentage of terminal exhausted TIM‐3+ LAG‐3+ PD‐1+ CAR T cells derived from CLL patients was observed compared to those derived from ALL patients (Figure S8D). Here, HAVCR2 is linked to acute lymphoblastic leukemia.